Physician profile
Safiul Hasan
NPI 1275636433
$1,333.65
in general payments reported to CMS, 2019-2025
16 companies · $197 in 2025
The $197 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $406 · 2020: $19.67 · 2021: $116 · 2022: $119 · 2023: $109 · 2024: $366 · 2025: $197.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $658 · Education: $13.76.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $658.33 |
| Education | $13.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $252.11 | 2024 | Caplyta |
| Abbvie INC. | $237.69 | 2021-2025 | |
| Sunovion Pharmaceuticals INC. | $124.99 | 2019 | |
| Axsome Therapeutics, INC. | $124.97 | 2025 | Auvelity |
| Neurocrine Biosciences, INC. | $121.81 | 2019 | |
| Janssen Biotech, INC. | $114.57 | 2023-2025 | Stelara, Tremfya |
| Nestle Healthcare Nutrition INC. | $62.84 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $58.07 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $51.15 | 2019-2025 | Eohilia |
| Braintree Laboratories, INC. | $45.61 | 2019-2021 | |
| Qol Medical, LLC | $32.77 | 2019-2022 | |
| Aimmune Therapeutics, INC. | $28.06 | 2024 | |
| Concordia Pharmaceuticals INC. | $24.61 | 2019 | |
| Redhill Biopharma INC. | $19.67 | 2020 | |
| Gilead Sciences, INC. | $18.92 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $15.81 | 2023 | Camzyos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Safiul Hasan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.